Related Experiment Video
Updated: Nov 5, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Factors Governing Selectivity of Dopamine Receptor Binding Compounds for D2R and D3R Subtypes
Hamed S Hayatshahi1, Robert R Luedtke2, Michelle Taylor2
1Department of Pharmaceutical Sciences, University of North Texas System College of Pharmacy, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, Texas 76107, United States.
Developing selective D3 receptor (D3R) drugs is challenging due to similarity with D2R. This study reveals molecular insights into D3R selectivity using computational simulations and ligand design, aiding future drug discovery.
Area of Science:
- Neuropharmacology
- Computational Chemistry
- Structural Biology
Background:
- Targeting the D3 dopamine receptor (D3R) offers therapeutic potential for various disorders.
- Structural similarities between D3R and D2R complicate the development of selective drugs.
Purpose of the Study:
- To investigate the molecular basis for high-affinity D3R binding and D3R vs. D2R selectivity.
- To understand how substituted phenylpiperazine thiopheneamides achieve D3R selectivity.
Main Methods:
- Molecular dynamics simulations (>10 μs) of D3R and D2R.
- Analysis of ligand binding modes and receptor conformations.
- Identification of key residues in extracellular loops and binding pockets.
Main Results:
- D3R and D2R exhibit distinct conformational dynamics (open/closed states), with D3R favoring the open state.
- Bitopic ligands shift equilibrium towards the closed conformation.
- Differences in extracellular loops and water displacement contribute to D3R selectivity.
Conclusions:
- Understanding receptor dynamics and ligand interactions is crucial for designing selective D3R agents.
- Bitopic ligand engagement and specific residue interactions in extracellular loops are key to D3R selectivity.
- This work provides a foundation for developing novel D3R-targeted therapeutics.
More Related Videos
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
07:41Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
Related Concept Videos
Dose-Response Relationship: Selectivity and Specificity
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Antipsychotic Drugs: Typical and Atypical Agents
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Quantitative Aspects of Drug-Receptor Interaction